Parenteral transmission of HIV among injection drug users: Assessing the frequency of multiperson use of needles, syringes, cookers, cotton, and water

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 18, Issue SUPPL., 1998, Pages

  McCoy, Clyde B ^a   Metsch, Lisa R ^a   Chitwood, Dale D ^a   Shapshak, Paul ^a   Comerford, Samuel T ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cooker; Cotton; Drug equipment; HIV; Injection drug users; Risk practices; Shating drugs and drug preparation equipment; Shooting galleries; Syringes; Water

Indexed keywords

WATER;

ARTICLE; COTTON; DATA ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INSTRUMENT; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; NEEDLE; PRIORITY JOURNAL; SYRINGE; UNITED STATES; VIRUS TRANSMISSION;

GOSSYPIUM HIRSUTUM; HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0032125130     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199802001-00006     Document Type: Article

References (41)

1. Battjes RJ, Pickens RW, Amsel Z. HIV infection and AIDS risk behaviors among intravenous drug users entering methadone treatment in selected U.S. cities. J AIDS 1991;4:1148-54.
2. Chaisson RE, Moss AR, Onishi R, Osmond D, Carlson J. Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. Am J Public Health 1987;77:169-72.
3. Chitwood DD, Griffin DK, Comerford M, et al. Risk factors for HIV-1 seroconversion among injection drug users: a case control study. Am J Public Health 1995;85:1538-42.
4. Hernandez-Aguado I, Bolumar F. Determinants of HIV-1 infection in intravenous drug users in Valencia, Spain, 1987-1991. Int J Epidemiol 1993;22:537-41.
5. Jose B, Friedman SR, Neaigus A, et al. Syringe-mediated drug-sharing (backloading): a new risk factor for HIV among injecting drug users. AIDS 1993;7:153-60.
6. Koblin BA, McCusker J, Lewis BJ, Sullivan JL. Racial/ethnic differences in HIV-1 seroprevalence and risky behaviors among intravenous drug users in a multisite study. Am J Epidemiol 1990; 132:837-46.
7. Lardelli P, DeLaFuente L, Alonzo JM, et al. Geographical variations in the prevalence of HIV infection among drug users receiving ambulatory treatment in Spain. Int J Epidemiol 1993;22:306-14.
8. Longshore D, Anglin MD, Hsieh SC, Annon K. Drug-related HIV risk behaviors and cocaine preference among injection drug users in Los Angeles. J Drug Educ 1993;23:259-72.
9. Marmor M, Des Jarlais DC, Cohen H, et al. Risk factors for infection with HIV among intravenous drug abusers in New York City. AIDS 1987;1:39-44.
10. McCusker J, Koblin B, Lewis BF, Sullivan J. Demographic characteristics, risk behaviors, and HIV seroprevalence among intravenous drug users by site of contact: results from a community-wide surveillance project. Am J Public Health 1990;80:1062-7.
11. Nicolosi A, Molinari S, Musicco M, et al. Positive modification of injecting behavior among intravenous heroin users from Milan and northern Italy 1987-1989. Br J Addict 1991;86:91-102.
12. Romano N, Vitale F, Alesi DR, et al. The changing pattern of human immunodeficiency virus type 1 infection in intravenous drug users. Am J Epidemiol 1994;135:1189-96.
13. Samuels J, Vlahov D, Anthony JC, et al. The practice of front-loading among intravenous drug users: associations with HIV antibody. AIDS 1991:5:343
14. Schoenbaum EE, Hartel D, Selwyn PA, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med 1989;321:874-9.
15. Vlahov D, Anthony JC, Celentano D, Solomon L, Chowdhury N. Trends of HIV-1 risk reduction among initiates into intravenous drug use 1982-1987. Am J Drug Abuse 1991;17:39-48.
16. Vlahov D. HIV seroconversion studies among intravenous drug users. AIDS 1994;8:263-5.
17. Agar MH. Ripping and running: a formal ethnography of heroin addicts. New York: Academic Press, 1973.
18. Booth R, Koester S, Reichardt R, Brewster JT. Quantitative and qualitative methods to assess behavioral change among injection drug users. Drugs Soc 1993;7:161-83.
19. Calsyn DA, Saxon AJ, Freeman G, Whittaker S. Needle-use practices among intravenous drug users in an area where purchase is legal. AIDS 1991;5:187-93.
20. Koester S. Copping, running, and paraphernalia laws: contextual variables and needle risk behavior among injection drug users in Denver. Human Organization 1994;53(3):287-95.
21. Mandell W, Latkin CA, Oziemkowska M, Vlahov D, Celentano D. Changes in HIV risk behaviors among counseled injecting drug users. J Drug Issues 1994;24:555-67.
22. O'Donnell JA, Jones JP. Diffusion of intravenous techniques among narcotic addicts in the United States. J Health Soc Behav 1968;9:120-30.
23. Valleroy LA, Weinstein B, Jones TS, et al. Impact of increased legal access to needles and syringes on community pharmacies' needle and syringe sales - Connecticut, 1992-1993. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:73-81.
24. Groseclose SL, Weinstein B, Jones TS, et al. Impact of increased legal access to needles and syringes on the practices of injecting-drug users and police officers - Connecticut. 1992-93. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:82-9.
25. Singer M, Weeks MR, Himmelgreen DJ. Sale and exchange of syringes [letter]. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:104.
26. Grund J-PC, Heckathorn DD, Broadhead RS, Anthony DL. In eastern Connecticut. IDUs purchase syringes from pharmacies but don't carry syringes [letter]. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:104-5.
27. Vlahov D. Deregulation of the sale and possession of syringes for HIV prevention among injection drug users. J Acquir Immune Defic Syndr Hum Rermvirol 1995;10:71-2.
28. McCoy CB, P Shapshak, Metsch LR, et al. HIV-1 prevention: interdisciplinary studies on the efficacy of bleach and development of prevention protocols. Arch Immunol Ther Exp 1995;43:1-9.
29. Normand J, Vlahov D, Moses LE, eds. Preventing HIV transmission: the role of sterile needles and bleach. Washington, DC: National Academy Press, 1995.
30. Chitwood DD, McCoy CB, Inciardi JA, et al. HIV seropositivity of needles from shooting galleries in South Florida. Am J Public Health 1990;80:150-2.
31. Grund JP, Kaplan CD, Adriaans NFP, et al. Drug sharing and HIV transmission risks: the practice of frontloading in the Dutch injecting drug using population. J Psychoactive Drugs 1991;23:1-10.
32. Koester S, Hoffer L. "Indirect sharing": additional HIV risks associated with drug injection. AIDS Public Policy J 1994;9: 100-5.
33. Page JB, Chitwood DD, Smith PC, Kane N, McBride DC. Intravenous drug abuse and HIV infection in Miami. Med Anthropol Q 1990;4:56-71.
34. Vlahov D, Khabbaz RF, Cohen S, Galai N, Taylor E, Kaplan JE. Incidence and risk factors for human T-lymphotropic virus type II seroconversion among injecting drug users in Baltimore. Maryland, U.S.A. J Acquir Immune Defic Syndr 1995;9:89-96.
35. Vlahov D. Backloading and HIV infection among injection drug users. Int J Drug Policy 1996;7:52-7.
36. Koester S, Booth RE, Zhang Y. The prevalence of additional injection-related HIV risk behaviors among injection drug users. J Acquir Immune Defic Syndr Hum Retrovirot 1996;12:202-7.
37. Needle RH, Coyle SL. (1997). Community-based outreach risk reduction strategy to prevent HIV risk behaviors in out-of-treatment injection drug users. NIH Consensus Development Conference on Interventions to Prevent HIV Risk Behaviors, February 13, 1997.
38. Weatherby NL, Needle R, Cesari H, et al. Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. Eval Prog Planning Eval Substance Abuse Interventions 1994;17(4):52-8.
39. Shah SM, Shapshak P, Rivers JE, et al. Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11(3):301-6.
40. Gershon RRM. Infection control basis for recommending one-time use of sterile syringes and aseptic procedures for injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18(Suppl 1):S20-4.
41. U.S. Public Health Service. HIV prevention bulletin: medical advice for persons who inject illicit drugs. Atlanta: Centers for Disease Control and Prevention, May 9, 1997.